Risk Of Developing Liver Cancer After HCV Treatment

Friday, June 30, 2017

Hepatitis C is a pediatric disease now

Related
Hepatitis C and women of childbearing age
July 03, 2017
A pregnant woman with evidence of HCV antibodies but no detectable active virus in her body is very unlikely to transmit HCV to her baby. On the other hand, pregnant women with very high viral loads are believed to be at increased risk for vertical transmission of HCV.

Commentary
Hepatitis C is a pediatric disease now
Publish date: June 27, 2017
By: Kristina K. Bryant, MD
It is estimated that there are 23,000 to 46,000 U.S. children living with HCV. The wait for pediatricians is over. HCV is a pediatric disease now, and we need to educate ourselves about diagnosis and management. A first step might be to begin asking expectant mothers and the mothers of newborns if they know their HCV status.
Continue reading....
Follow @IDPractitioner  

Recommended Reading
Hepatitis C increasing among pregnant women
Published:



FDA approves two hepatitis C drugs for pediatric patients
Published: April 7, 2017
The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.
Read the announcement @ FDA Newsroom

FDA Approval Of Hepatitis C Drugs For Kids Is Likely To Speed Treatment









I highly suggest you follow Henry E. Chang on Twitter if you are interested in reading full text articles about the treatment and management of hepatitis C. 

No comments:

Post a Comment